Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.

NCT05601180 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Chronic Obstructive Pulmonary Disease
Long COVID

Interventions

OTHER: Respicure®
OTHER: Standard of care

Sponsor

Beker Laboratories